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A gene encoding a novel CACCC box-binding protein that binds to the promoter region of the human T-cell
receptor (TCR) Vf%8.1 gene and the mouse TCR a gene silencer has been cloned. This gene, termed htI,
contains four zinc fingers of the dass Cys2-Xl2-His2 that may be responsible for DNA binding and a highly
negatively charged region that defines a putative transcriptional activation domain. Analysis of the expression
of htf mRNA revealed similar expression levels and patterns in various cell lines. The bacterially expressed ht(3
protein can bind to the CACCC box in both the human TCR V,B8.1 gene promoter and the mouse TCR a gene
silencer. The CACCC box is essential for efficient transcription of the V,B8.1 promoter. Cotransfection with an
ht$ expression plasmid and a reporter vector indicated that htM can activate human TCR V138.1 gene
transcription. ht13 also is able to counteract the silencing effect of the mouse TCR a gene silencer. The CACCC
box has been found in almost al V138.1 gene subfamily members and in both TCR a and ,B gene enhancers in
humans and mice. These results suggest that the CACCC box-binding protein may have an important
regulatory function for TCR gene expression in ao T cells versus 'y8 T cells.
T cells recognize antigens in the context of the self major
histocompatibility complex via a clonally expressed T-cell
receptor (TCR). The genes encoding TCR a, 1, -y, and 8
chains have been characterized (6-8, 20, 27, 41, 42, 56).
Each of the four TCR genes consists of multiple germ line
gene segments that rearrange during T-cell development to
generate a mature T-cell population with clonally distributed
receptors (29).
While the genomic organization of the four TCR genes has
been well established, the regulation of the rearrangement
and expression of these genes in the different T-cell subsets
is relatively unknown. Recent studies have described tran-
scriptional enhancers and silencers in human and murine
TCR genes (22, 29, 34, 52, 53) and two DNA-binding
proteins that interact with the human TCR a gene enhancer
(52). Studies aimed at examining the question of the tissue
specificity of VP promoters revealed that the human TCR
V18.1 promoter is only active in T cells (9), implying that
there are some T-cell-specific transcription factors that bind
to the identified V18.1 promoter. A conserved decamer
motif 10 to 40 bp upstream of the TATA box has been
identified in the murine VP promoters (1). This decamer also
is present in the human V,B8.1 promoter (45). Royer and
Reinherz (40) have shown that there are four regions to
which transcription factors bind in the 175-bp fragment of
the human V138.1 promoter. One of the regions, a 21-bp
GT-rich motif 72 bp upstream of the transcription initiation
site, was only protected by nuclear extracts from T-cell
lines, not other cell lines, in a DNase footprinting study (40).
The results suggest that T-cell-specific transcription factors
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may bind to the 21-bp GT-rich motif. There is a CACCC box
that is reversely oriented in the 21-bp GT-rich region.
The CACCC box was first found in the 3-globin gene
promoter region and was required for efficient and accurate
1-globin gene expression. A mutation in the CACCC box
region strongly reduced transcription, suggesting that the
CACCC box is an important promoter element (10). The
CACCC box was observed not only in most members of the
globin gene family but also in the erythroid transcription
factor GATA-1 promoter (49), slow/cardiac troponin C gene
enhancer (36), rat gastric H+/K+-ATPase v gene promoter
(32), glucocorticoid receptor gene promoter (19), and mouse
immunoglobulin germ line Cyl gene promoter (55). CACCC
box-binding proteins may function as important general
transcription factors for gene expression. In addition to
activating transcription by interacting with DNA sequences,
the CACCC box-binding proteins interact with other tran-
scription factors to carry out more functions (19, 44). Al-
though the binding activities of multiple transcription factors
have been well characterized, the isolation of a gene for a
transcription factor that binds to the CACCC box has not
been reported.
We now report the isolation and characterization of a
novel cDNA gene encoding a CACCC box-binding protein,
ht1, that recognizes the CACCC box in both the human TCR
V,B8.1 gene promoter and the mouse TCR a gene silencer. A
functional analysis of the effect of the htp protein on TCR
gene expression is presented, and the implication that this
protein regulates the type of TCR (a1 or y8) expressed on T
cells is discussed.
MATERIALS AND METHODS
Oligonucleotides. The primers used for amplification of the
mouse TCR a gene silencer I fragment (53) from mouse
genomic clone TA4.1 (54) were as follows: primer 1, 5'
CTCGAGCAACATGTGGGAAGA 3'; and primer 2, 5'
CAGCTGTCTGTGTGATTCITG 3'. The double-stranded
probe used in the gel shift assays was produced by use of the
oligonucleotides 5' GATCTGGGGGTGGGGTGGGGGTGG
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GGTGGGGGTGGGG 3' and 5' GATCCCCCACCCCCAC
CCCACCCCCACCCCACCCA 3'; the CACCC boxes
are underlined. The oligonucleotides used for gel shift com-
petition assays had two 17-mer GAL4 factor-binding sites
(16): 5' CGGAGTACTGTCCTCCGCGGAGTACTGTCCTC
CGCTGC 3' and 5' GCAGCGGAGGACAGTACTCCGCG
GAGGACAGTACTCCG 3'.
Library screening. A Xgtll cDNA library prepared with
mRNA from phytohemagglutinin-stimulated human periph-
eral blood T cells (Clontech) was screened by the method of
Vinson et al. (50). Plaques (2 x 106) were screened at a
density of 2 x 104 per filter after lytic infection of Esche-
richia coli Y1090. The probes used for screening the Xgtll
cDNA library were generated from two complementary
oligonucleotides corresponding to the sequence of the hu-
man TCR V38.1 promoter element from positions -72 to
-92 (9): 5' AAT'TTlAAAGAAGTTGGGGGTGGTG 3' and
5' AATTCACCACCCCCAACTTCI1TvrAA 3'. The probes
used in the screening were prepared by nick translation of
size-selected, double-stranded catenated oligonucleotides
with [a32P]dATP and [a32P]dCTP (33). The EcoRI inserts
from positively selected plaques were subcloned into Blue-
script-KSII (-) for sequence analysis by the dideoxy chain
termination method for both strands (33). A Agtll cDNA
library made with Jurkat T-cell-line-derived mRNA by use of
cDNA SYNTHESIS SYSTEM PLUS (Amersham) was con-
structed for isolating full-length ht, cDNA.
Southern and Northern (RNA) analyses. Total genomic
DNAwas isolated from the human T-cell lymphoma-derived
cell line Jurkat. DNA (10 ,ug) was digested with EcoRI,
HindIII, BamHI, andXbaI, resolved on an 0.8% agarose gel,
and transferred to a nylon membrane (Zeta-Probe; Bio-Rad).
Southern hybridization was carried out at 37°C overnight
with 2.5 x 106 cpm of denatured probe per ml (5x SSC [lx
SSC is 0.15 M NaCl plus 0.015 M sodium citrate], 20 mM
sodium phosphate [pH 6.7], 10% dextran sulfate, 1% sodium
dodecyl sulfate [SDS], 0.5% powdered milk, 100 p.g of
denatured salmon sperm DNA per ml, 50% formamide).
Washes were carried out three times in 0.lx SSC-0.1% SDS
at 65°C for 15 min each time.
The sources of the human RNAs were T-cell line Jurkat
(ATCC CRL 8163), B-cell line Ramos (ATCC CRL 1596),
monocyte line U-937 (ATCC CRL 1593), and HeLa cells
(ATCC CCL2). RNAs were isolated from these cell lines by
the guanidinium method (33), and poly(A)+ RNAs were
selected by oligo(dT)-cellulose chromatography (3). For
Northern blot analysis, 10 ,g of poly(A)+ RNAwas resolved
on a formaldehyde gel (33) and transferred to a nylon
membrane (Zeta-Probe GT; Bio-Rad). Hybridization and
washes were performed by the procedures recommended by
the membrane manufacturer. RNA molecular weight mark-
ers were purchased from GIBCO-BRL.
Bacterial expression and DNase I footprinting assays. The
bacteriophage T7 expression system was used for the pro-
duction of the htI protein (47). A DNA fragment containing
a portion of the htI3 coding sequence, including the four zinc
fingers, was created with NdeI and BclI sites at the ends by
use of appropriate oligonucleotides and polymerase chain
reaction amplification. It was cloned into the NdeI and
BamHI sites of vector pET3a. This plasmid was transformed
into strain BL21(DE3), which has the T7 RNA polymerase
gene under lacUVS promoter control. Transformed bacteria
were induced with 1 mM isopropyl-3-D-thiogalactopyrano-
side (IPTG) at an optical density at 600 nm of 0.7 for 4 h and
harvested. Extracts were prepared by the method of Hoey
and Levine (23), as modified by Treisman and Desplan (48).
The probes for DNase I footprinting were either RsaI-
XbaI or Hinfl-NcoI fragments from the human V08.1 pro-
moter region. They were isolated from cosmid H7.1 (45) and
labeled at one end by the filling-in method with Klenow
DNA polymerase (33). DNase I footprinting assays were
performed as described by Galas and Schmitz (14). The
binding reactions were carried out with 3 to 5 ng of 32p_
labeled DNA and 2,g of poly(I-C) (Boehringer Mannheim)
in a 30-,ul reaction volume for 20 min on ice. The composi-
tion of the binding reaction mixture was as described by Fan
and Maniatis (12). After binding was accomplished, 4 ,ul of
100 mM MgCl2-150 mM CaCl2 was added to the reaction
mixture, and then 1 ,ul of freshly diluted DNase I (Worthing-
ton) at a final concentration of 25 ,g/ml was added. DNase I
digestion was stopped after 1 min on ice by the addition of
the stop solution described by Hoey and Levine (23). The
samples were extracted twice with phenol-chloroform (1:1)
and once with chioroform, ethanol precipitated, and electro-
phoresed in a 6% polyacrylamide-8 M urea gel.
Plasmid construction. (i) Expression plasmids. The full-
length ht,B cDNA was subcloned into the EcoRI site of
pSG5, a eukaryotic expression vector (Stratagene) in which
the full-length hto cDNA is under the control of the simian
virus 40 (SV40) early promoter.
(ii) Reporter plasmids. The human V38.1 promoter region
(9) at various lengths was subcloned into the pCAT enhancer
plasmid (Promega), which has a chloramphenicol acetyl-
transferase (CAT) gene and an SV40 enhancer but lacks the
promoter. For pV38.1CAT, the MseI-BstNI (positions -91
to +17) fragment of human V,B8.1 was blunt ended with
Klenow DNA polymerase and then ligated to the XbaI-
digested, blunt-ended pCAT enhancer plasmid. Plasmid
pAV38.1CAT was constructed by subcloning a blunt-ended
HaeIII fragment (positions -71 to +14) into the pCAT
enhancer plasmid. The oligonucleotide containing five re-
peats of CACCC was ligated to HindIII-digested, blunt-
ended pAV38.1CAT, placing the five repeats of CACCC
upstream of the V18.1 promoter HaeIII fragment. The
resulting plasmid was named pOAV,38.1CAT.
The mouse TCR a gene silencer I fragment (53) was made
by PCR amplification of mouse genomic clone TA4.1 (54)
and confirmed by DNA sequence analysis. The 309-bp
mouse TCR silencer I fragment was ligated to either BglII-
or XbaI-cleaved, blunt-ended pCAT control plasmid (Pro-
mega), which has an SV40 promoter, an SV40 enhancer, and
a CAT gene. The mouse TCR a gene silencer was placed
either upstream of the SV40 early promoter when digestion
was done with BglII (named pControl sil 5') or downstream
of the SV40 enhancer when digestion was done with XbaI
(named pControl sil). All the plasmid constructs were con-
firmed by DNA sequence analysis.
Nuclear extract preparation and gel shift assays. HeLa cells
were grown in Dulbecco modified essential medium (DMEM)
containing 10% fetal calf serum (FCS). U-937, Ramos, and
Jurkat cells were grown in RPMI 1640 medium containing
10% FCS. Cells were harvested in the log phase, and nuclear
extracts were prepared as described by Schreiber et al. (43).
Gel shift assays were performed under the conditions de-
scribed by Fan and Maniatis (12). Nuclear extracts (10 ,ug)
were incubated with 2.5 ng of 3 P-labeled probe and 2.5 ,ug of
poly(I-C) on ice for 20 min. The reaction mixtures were
loaded on a 6% polyacrylamide-0.5x TBE (Tris-borate-
EDTA buffer) gel.
Transfection. HeLa cells were transfected with plasmid
DNA by use of liposomes (2). In brief, exponentially grow-
ing cells were plated in six-well tissue culture dishes at 5 x
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FIG. 1. cDNAs and predicted protein structure of ht,B. The overlapping cDNAs htP16 and ht,8 were isolated from a human peripheral
T-cell cDNA library, and cDNA htj3 was isolated from a Jurkat T-cell-line cDNA library. Restriction enzyme sites: K, Kp4nI; R5, EcoRV;
P, PstI. A schematic diagram of the predicted ht,B protein structure is shown, with three cDNA clones aligned with the protein structure. The
interesting motifs in the protein are indicated. The vertical arrow indicates the translation start site, and the asterisk indicates the stop codon.
105 cells per well and grown overnight. Plasmid DNA was
mixed with 20 ,ug of Lipofectin reagent (GIBCO-BRL) in 1
ml of serum-free DMEM. One milliliter of the DNA-lipo-
some complex was added directly to the cells. Incubation for
3 h at 37°C was followed by the addition of 1 ml of DMEM
containing 20% FCS. Cells were harvested 48 h after trans-
fection for CAT assays.
The DEAE-dextran method (13) was used for the trans-
fection of Jurkat cells. Cells (5 x 106) were incubated in 1 ml
of Tris-buffered saline containing plasmid DNA and 500 ,ug
of DEAE-dextran (Promega) per ml for 30 min at room
temperature. Cells were then washed with Tris-buffered
saline and incubated in 20 ml of RPMI 1640 medium con-
taining 10% FCS for 48 h. As a control for differences in
transfection efficiencies, 0.5 to 1 ,ug of a P-galactosidase
gene-containing plasmid (pCMV-lacZ; a kind gift from Ebra-
him Zandi, Department of Chemistry and Chemical Engi-
neering, California Institute of Technology) was included in
each transfection.
CAT assays and 1-galactosidase assays. Cells (HeLa) were
harvested by scraping with a rubber policeman, centrifuged,
and then washed once with phosphate-buffered saline. Cells
were resuspended in 100 p,l of 0.25 M Tris-HCl (pH 7.4) and
subjected to three cycles of freeze-thaw lysis in liquid
nitrogen. The subsequent assays were done as described by
Gorman et al. (17) with 0.2 p,Ci of [14C]chloramphenicol
(Amersham) and 25 p,g of acetyl coenzyme A (Sigma) for
each reaction. The acetylated and nonacetylated forms of
chloramphenicol were excised from the thin-layer chromato-
graphs, and the amount of radioactivity was determined by
liquid scintillation counting. The P-galactosidase assays
were done as described previously (33) with o-nitrophenyl-
3-D-galactopyranoside (Sigma) as a substrate. The amounts
of cell extracts used for CAT assays were optimized on the
basis of P-galactosidase assay results.
Nucleotide sequence accession number. The sequence re-
ported in this paper has been deposited in the GenBank data
base under accession number L04282.
RESULTS
Isolation and DNA sequence of the ht3 gene. A DNA probe
containing the sequence from positions -72 to -92 of the
human V18.1 promoter was used to screen a Xgtll expres-
sion library constructed from T-cell-derived mRNA. The
screening of 2 x 106 plaques yielded two positive clones.
One of the clones, htMO6, contained a 1.8-kb insert that was
subcloned into Bluescript-KSII (-) for sequence analysis.
Using the 1.8-kb ht316 insert to rescreen the same library,
we found a clone, htM8, that overlaps the 3' sequence of
ht,B16. Another clone, htf3, which has a 1.8-kb insert,
overlaps for 1 kb the 5' sequence of ht116 (Fig. 1). This clone
was isolated from a Agtll library made with Jurkat T-cell-
line-derived mRNA. Southern blotting of Jurkat T-cell-line
genomic DNA digested with EcoRI, BamHI, HindIII, and
XbaI and probed with the 1.8-kb htP16 fragment indicated a
dominant single band, although some faint bands appeared
upon longer exposure (data not shown).
The DNA sequence of htI was determined (Fig. 2). The
sequence predicts a long open reading frame of 1,362 nucle-
otides that is terminated by six in-frame stop codons. The
3'-untranslated region is 666 nucleotides long. The poly(A)
site was not identified. The nucleotide sequence of the open
reading frame was translated into its corresponding 454-
amino-acid sequence. The molecular mass of the ht,B protein
encoded by the full-length mRNA is approximately 49 kDa.
Inspection of the amino acid sequence shown in Fig. 2
indicates that the htI protein has four tandem zinc fingers
near the middle of the open reading frame. The first two
finger motifs have the general form Cys-X2-C'ys-X3-Phe-X5-
Leu-X2-His-X3-His. The third and fourth fingers have the
modified forms Cys-X2-Cys-X8-His-X3-His and Cys-X2-Cys-
X3-Phe-X6-Leu-X1-His-X4-His, respectively. At the amino-
terminal side of the zinc finger region is a highly acidic
segment (residues 54 to 99) that has the potential to form an
ao-helix. This segment has a net charge of -12. Other
features of interest in the htI sequence include a highly basic
segment (residues 129 to 153) at the amino-terminal side of
1.6 Kb
VOL. 13, 1993
5694 WANG ET AL.
1 GAATTCCGGAGAAAGGCGCAGGGGTGGGAGCTGTTGCCGAAGCTGCCACAGCAAAAGTTC 60
61 TCCCCCCTCCCCCCTTCCCCTCCTCTCAAGGCCCCTAGAAAGGTTGGAGCTGCCGGCCCT 120
121 GCAGTCGGTGACCGCTGACGACTTCGGCCGCGCCCGCGGATAGAGGGAGGAATCAGCAGC 180
181 TTGGAAATTCAAGCACGTGATCTGGCGGGATGGCGTTTGCCTAACGTATTTAATGGAGGA 240
241 ATCGGATGGCATAAGTGATTAAGGTGGTATTGAGGATTTCTGAAGCCTATGAAAGGTAGA 300
301 AACTCAACCATGATTTCTTTTTCAACTCTACAGCATTCCTTTCCTTGAAGTCTTCGTTTT 360
361 TACCTTAGTCTCGGGCAGTTATACTTAAGCATGAACATTGACGACAAACTGGAAGGATTG 420
M N I D D K L E G L 10
421 TTTCTTAAATGTGGCGGCATAGACGAAATGCAGTCTTCCAGGACAATGGTTGTAATGGGT 480
F L K C G G I D E M Q S S R T M V V M G 30
481 GGAGTGTCTGGCCAGTCTACTGTGTCTGGAGAGCTACAGGATTCAGTACTTCAAGATCGA 540
G V S G Q S T V S G E L Q D S V L Q D R 50
541 AGTATGCCTCACCAGGAGATCCTTGCTGCAGAT AAGTGTTACAAGAAAGTGAAATGAGA 600
S M P H Q ® I L A A ® ( V L Q ® S ® m ® 70
601 CAACAGGATATGATATCACATGATGAACTCATGGTCCATGAGGAGACAGTGAAAAATGAT 660
Q Q ® M I S H ® ®L M V H T V ® N® 90
661 GAAGAGCAGATG AAACACATGAAAGACTTCCTCAAGGACTACAGTATGCACrTAATGTC 720
Q M @T H ®® L P Q G L Q Y A L N V 110
721 CCTATAAGCGTAAAGCAGGAAATTACTTTTACTGATGTATCTGAGCAACTGATGAGAGAC 780
P I S V K Q E I T F T D V S E Q L M @® 130
781 AAAAAACAAATCAGAGAGCCAGTAGACTTACAGAAAAAGAAGAAGCGGAAACAACGTTCT 840
®® Q I ® P V ® L Q®® Q®® S 150
841 CCCGCAAAAATCCTTACAATAAATGAGGATGGATCACTTGGTTTGAAAACCCCTAAATCT 900
_PA®@ I L T I N E D G S L G L K T P K S 170
901 CACGTTTGTGAGCACTGCAATGCTGCCTTTAGAACGAACTATCACTTACAGAGACATGTC 960
H V C E H C N A A F R T N Y H L Q R H V 190
961 TTCATTCATACAGGTGAAAAACCATTTCAATGTAGTCAATGTGACATGCGTTTCATACAG 1020
F I H T G E K P F Q C S Q C D M R F I Q 210
1021 AAGTACCTGCTTCAGAGACATGAGAAGATTCATACTGGTGAAAAACCATTTCGCTGTGAT 1080
K Y L L Q R H E K I H T G E K P F R C D 230
1081 GAATGTGGTATGAGATCCATACAAAAATATCATATGGAAAGGCATAAGAGAACTCATAGT 1140
E C G M R S I Q K Y H M E R H K R T H S 250
1141 GGAGAAAAACCrTACCAGTGTGAATACTGTTTACAGTATTTTTCCAGAACAGATCGTGTA 1200
G E K P Y Q C E Y C L Q Y F S R T D R V 270
1201 TTGAAACATAAACGTATTGGCCATGAAAATCATGACAJ.AAAACTAAATACATGTGCCATG 1260
L K H K R I G H E N H D K K L N T C A M 290
FIG. 2. DNA sequence and predicted amino acid sequence of ht3. The amino acid sequence predicted from the longest reading frame of
htp is shown. The zinc finger motifs are indicated by underlining; the highly acidic segment that occurs amino terminal to the zinc fingers is
denoted by double underlining, and the charged amino acids are circled. Basic segments that are located before and after the zinc fingers are
indicated by broken underlining, and the charged amino acids are circled. The six in-frame stop codons begin at the asterisk.
the zinc finger region and another basic segment (residues ht3 encodes a 40-kDa protein composed of 365 amino acids.
314 to 344) downstream of the fingers. The deduced molecular weight of this protein is the same as
ht encodes a protein that can bind to the CACCC boxes of the size determined by SDS-polyacrylamide gel analysis
the human TCR Vj38.1 gene promoter and the mouse TCR a (data not shown). Crude lysates of E. coli BL21(DE3)
gene silencer. A fragment of htI (residues 81 to 445) contain- containing pET3a-htP were tested for DNA-binding activity
ing most of the coding region was expressed in E. coli. A by DNase I footprinting with the human TCR VP8.1 pro-
portion of the acidic region is missing from the expressed moter element. Extracts prepared from BL21(DE3)(pET3a-
protein, but all four zinc fingers are present. Plasmid pET3a- htp) but not BL21(DE3)(pET3a) were found to protect
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1261 AAAGGTGGCCTTCTGCGCTCTGAGGAAGATTCTGGCTTTTCTACATCACCAAAAGACAAC
K G G L L R S E E D S G F S T S P K D N
1321 TCACTGCCAAAAAAGAAAAGGCAGAAAACGGAGAAAAAATCATCTGGAATGGACAAAGAG
S L P ® ® ® Q T®S S G M@ E
1381 AGTGCTTTGGACAAATCTGACCTGAAAAAAGACAAAAATGATTACTTGCCTCTTTATTCT
S A L D K S D L K K D K N D Y L P L Y S
1441 TCAAGTACTAAAGTAAAAGATGAGTATATGGTTGCAGAATATGCTGTTGAAATGCCACAT
S S T K V K D E Y M V A E Y A V E M P H
1501 TCGTCAGTTGGGGGCTCGCATTTAGAAGATGCGTCAGGAGAAATACACCCACCTAAGTTA
S S V G G S H L E D A S G E I H P P K L
1561 GTTCTCAAAAAAATTAATAGTAAGAGAAGTCTGAAACAGCCACTGGAGCAAAATCACACA
V L K K I N S K R S L K Q P L E Q N H T
1621 ATTTCACCTTTATCCACATATGAAGAGCGAAAGTTTCAAAGTATGCTTTTGAACTTGTGG
I S P L S T Y E E R K F Q S M L L N L W
1681 ATAAACAGGCTTTACTGGACTCAGAAGGCAATGCTGACATTGATCAGGTTGATAATTTGC
I N R L Y W T Q K A M L T L I R L I I C
1741 AGGAGGGCCCAGTAAACCTGTGCATAGTAGTACTAATTATGATGATGCCATGCAG[TTTT
R R A Q *
1801 GAAGAAGAAGCGGTATCTTCAAAGCAAGTAACAACAGCAGGGAATATGCGCTGAATGTGG
1861 GTACCATACGTTCTCAGCCTTCTGTAACACAAGCAGCTGTGGCAAGTGTCATTGATGAAA
1921 GATCCACGGCATCCATATTAGAGTCACAGGCACTGAATGTGGAGATTAAGAGTAATCATG
1981 ACAAAAATGTGTTATTCCAGATGAGGTACTGCAGACTCTGTTGGATCATTATTCCCACAA
2041 AGCTAATGGACAGCATGAGATATCCTTCAGTGTTGCAGATACTGAAGTGACTCTAGCATA
2101 TCAATAAATTCTTCAGAAGTCCAGAGTCACCCCGTCAGAGAATGTTGATCAAGCTCCCAA
2161 GCATCCTCATCAGATAAAGCCAACATGTTGCAGGAATACTCCAAGTTTCTGCAGCAGGCT
2221 TTGGACAGAACTAGCCAAAATGATGCCTATTTGAATAGCCCGAGCCTTAACTTTGTGACT
2281 GATAACCAGACCCTCCCAAATCAGCCAGCATTCTCTTCCATAGACAAGCAGGTCTATGCC
2341 ACCATGCCCATCAATAGCTTTCGATCAGGAATGAATTC 2378
FIG. 2-Continued.
nucleotides GAAGTTGGGGGTGGTG of the Vf38.1 pro-
moter from digestion by DNase I (data not shown). The
DNase I footprinting assay was done with both coding and
noncoding strands of the V138.1 promoter, and the protected
regions were about the same. The 365 amino acid residues of
the truncated htp protein that include the four zinc fingers
are sufficient for sequence-specific binding of the htI protein
to DNA.
The mouse TCR a gene silencer I sequence has a region
(53) that is highly similar to the htj-binding site in the TCR
V08.1 gene promoter. Crude lysates of E. coli BL21(DE3)
containing pET3a-htP were tested for DNA-binding activity
by DNase I footprinting with the mouse TCR a gene silencer
I fragment. Extracts prepared from BL21(DE3)(pET3a-ht,B)
protected the 163- to 193-bp region of the mouse TCR a gene
silencer from digestion by DNase I (data not shown).
When the ht,B-binding sites in both the human TCR V,8.1
gene promoter and mouse TCR a gene silencer I were
compared (Fig. 3), a consensus sequence, TGGGGGTGG,
which contains the complement of the well-known CACCC
box in the center, was found (10). For determination of
whether only this CACCC motif is necessary for htf protein
binding, double-stranded oligonucleotides containing five
repeats of the CACCC box were synthesized, annealed, and
labeled with 32P as probes for a gel shift analysis. The probes
formed DNA-protein complexes with extracts prepared from
BL21(DE3)(pET3a-ht3) but not BL21(DE3)(pET3a) (Fig. 4).
This result clearly shows that CACCC is the core sequence
for ht, binding. Very likely htp is one of the long-sought
CACCC box-binding proteins.
In addition, nuclear extracts from HeLa cells, U-937
monocytes, Ramos B cells, and Jurkat T cells were tested
with the same probes containing five CACCC boxes in a gel
shift assay. Four common bands were visible with all nuclear
extracts tested, and an additional, fast-moving band was
seen with extracts from HeLa cells (data not shown). For
demonstration of the specificity of binding to the CACCC
box, excess amounts of unlabeled CACCC-containing oligo-
nucleotides or GALA-binding-site-containing oligonucleo-
tides with no homology to the CACCC box were added to
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htf binding site
Human TCR V38.1 promoter
Mouse TCR aX silencer I
(-87) GAAGT GGGGGTGGrG (-72)
(163) CTACGGGrGGGGGTGGGGTGGGGTGGGGGGC (193)
FIG. 3. Comparison of the ht,B-binding sites in the human TCR V,B8.1 gene promoter (positions -87 to -72) and mouse TCR a gene
silencer I (positions 163 to 193). The homologous regions in the binding sites are boxed.
the reaction mixture of 32P-labeled CACCC-containing oli-
gonucleotides and either HeLa cell or Jurkat cell nuclear
extracts. All bands in the HeLa cell extract assay were
efficiently inhibited through competition by 20 to 50 ng of a
cold CACCC-containing fragment but not by 50 ng of a
GAL4-binding-site-containing oligonucleotide. In Jurkat T
cells, three bands were inhibited through competition by a
20-fold molar excess of a specific CACCC-containing frag-
ment (data not shown). A rabbit polyclonal anti-ht3 antibody
did not successfully compete for binding, although the
antibody has been shown to bind E. coli-expressed ht,
protein by Western blot (immunoblot) analysis (data not
shown).
Expression of ht mRNA. For studying the pattern of
E. coli Extracts: pET3a-htp pET3a
LOC~U)N I)
Qg -0 N N
expression of the hto gene, RNA was isolated from various
tissue culture cell lines. Poly(A)+ RNAs were selected by
oligo(dT)-cellulose chromatography and detected by North-
ern blot analysis with the 1.8-kb segment of ht316 as a probe.
As shown in Fig. 5, three RNA species, with estimated sizes
of 4.2, 7.6, and 8.6 kb, were detected. The same blot was
rehybridized with the EcoRI-EcoRV fragment of ht13,
which does not contain the zinc finger region, and again
three RNA species with the same sizes as shown in Fig. 5
were seen. For controlling for potential variations in the
levels of RNA electrophoresed, the blot was rehybridized
with a human f-actin probe. Comparable levels of hybrid-
ized RNA were observed with the ,B-actin probe, indicating
that the levels of expression of ht, are not significantly
different in the four cell lines tested.
htM activates human TCR VP8.1 gene expression and
antagonizes the function of the mouse TCR ax gene silencer.
CD
n E cO
htV3 probe I: D -
Kb
9,5 -
7.5 -
FIG. 4. Gel shift assay of synthetic oligonucleotides containing
five repeats of the CACCC box with protein extracts from bacteria
containing plasmid pET3a-ht3. From left to right, lanes contained 0,
0.25, 0.5, 1, and 2 .g of protein extracts from bacteria containing
pET3a-ht(p. The rightmost lane contained 2 Fg of protein extracts
from bacteria containing only pET3a, the vector.
4.4-
2.4 -
1.4-
Control
FIG. 5. Northern blot analysis of poly(A)+ RNAs from various
cell lines. Poly(A)+ RNAs were loaded at 10 ,ug in each lane. The
blot was hybridized with a labeled 1.8-kb insert of htMM6.
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FIG. 6. Transcriptional activity of the human V80.1 promoter. The constructs pVI8.1CAT, pAV38.1CAT, and pOAVI38.1CAT were
described in Materials and Methods. The transcription start site of the SV40 promoter is indicated by an arrow. En, enhancer. (a) HeLa cells
were transfected with 2 p.g of various V18.1 promoter constructs and 0.5 ,ug of pCMV-lacZ by the liposome method. (b) Jurkat cells were
transfected with 5 ,ug of various V18.1 promoter constructs and 1 pg of pCMV-lacZ by the DEAE-dextran method. In both cases, the amounts
of cell extracts used in the CAT assay were optimized on the basis of P-galactosidase activities.
For studying the importance of the CACCC box in TCR
V18.1 transcription, various V18.1 promoter constructs
were made and analyzed for expression in both HeLa and
Jurkat T cells (Fig. 6). Plasmid pVP8.1CAT, which contains
the natural CACCC box in the V,B8.1 gene promoter, had
significant CAT activity. However, for pAVI38.1CAT, which
has a deletion of the upstream CACCC, CAT activity was
dramatically decreased, to about 5 and 2% of the transcrip-
tional activities of pV38.1CAT in HeLa and Jurkat cells,
respectively. The addition of five repeats of the CACCC box
upstream of the VP8.1 promoter in plasmid pAVP8.1CAT
increased CAT activity greatly; 59 and 100% of the transcrip-
tional activities of pV,8.1CAT were restored in HeLa and
Jurkat cells, respectively.
For studying the regulatory function of the htI protein, the
full-length htf cDNA was subcloned into pSG5, a eukaryotic
gene expression vector, under the control of the SV40 early
promoter. The expression plasmids were cotransfected into
HeLa cells with plasmid pV,B8.1CAT, which has a Vf8.1
promoter containing the CACCC box followed by a CAT
gene. Because of the presence of endogenous htp protein,
cotransfection with the htp expression plasmid and reporter
plasmid pV,B8.1CAT resulted in a modest increase in CAT
activity, compared with that in the transfection with the
reporter plasmid alone. The twofold increase in CAT activity
was very reproducible (Fig. 7). The htp protein was able to
activate transcription of the human V,B8.1 gene.
Besides binding to the V18.1 promoter, htp also can bind
to another TCR regulatory sequence, mouse TCR a gene
silencer I. The regulation of mouse TCR a gene silencer I by
the htj protein was investigated. The presence of mouse
TCR a gene silencer I downstream of the SV40 enhancer
(pControl sil) and upstream of the SV40 promoter (pControl
sil 5') resulted in decreased transcription (approximately 40
and 67%, respectively) (Fig. 8), while cotransfection of
pControl sil or pControl sil 5' with pSG5-ht3 restored
transcription to 97 or 61%, respectively. These results indi-
cate that htI can reverse the silencing function of the mouse
a gene silencer.
DISCUSSION
An oligonucleotide probe that corresponds to the se-
quence of the human TCR VP8.1 promoter element from
positions -72 to -92 and that contains a CACCC box was
used to isolate a cDNA clone from a Xgtll expression library
prepared from human peripheral T-cell mRNA. This cDNA
hybridizes to three mRNA species present in a variety of cell
types, including HeLa cells, U-937 monocytes, Ramos B
cells, and Jurkat T cells. The three mRNA species may
reflect alternative mRNA splicing of the htI gene, or the 7.6-
and 8.6-kb mRNA species could be unspliced forms of the
4.2-kb mRNA. Other cDNA segments containing overlap-
ping sequences were isolated from the above-described
library or a library prepared from Jurkat-cell-line-derived
RNA. The sequence of a composite cDNA of 3.6 kb was
partially determined. Translation of this sequence revealed a
long open reading frame of 454 amino acid residues encoding
a protein of approximately 49 kDa. hto may be a single-copy
1 2
Ac-Chl
T t]OChl
Reporter plasmid (2ug)
Expression plasmid (2ug)
Relative CAT activity
pVO8.1CAT pV:8.1CAT
pSG5 pSG5-ht3
1 1.9±0.28
FIG. 7. Activity of the htp protein on the human VP8.1 pro-
moter. Two micrograms of reporter plasmid pV38.1CAT was
cotransfected with 2 pLg of expression plasmid pSG5 (lane 1) or
pSG5-htp (lane 2) into HeLa cells by the liposome method (15). An
internal control (pCMV-lacZ) (0.5 ,ug) was included in each trans-
fection. The relative CAT activities were calculated. Ac-Chl, acety-
lated chloramphenicol.
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FIG. 8. Activity of the htI3 protein on mouse TCR a gene silencer I. (a) Schematic organization of reporter and expression plasmids.
Mouse TCR a gene silencer I (sil I) was inserted upstream of the SV40 promoter (PSV40) or downstream of the SV40 enhancer (SV4OEn).
The full-length htl cDNA was inserted at the EcoRI site of vector pSG5, which contains an SV40 early promoter. The transcription start site
of the SV40 promoter is indicated by an arrow. (b) Effect of the htp protein on mouse TCR a gene silencer I. HeLa cells were cotransfected
with a reporter plasmid (2 ,ug) and activator plasmid pSG5-ht,B (2 ,ug) or parental vector pSG5, together with 0.5 ,ug of internal control plasmid
pCMV-lacZ. The CAT activity of the pControl transfection was considered 100%, and the relative CAT activities of the other transfections
were calculated.
gene, since Southern blot analysis with digests of human
genomic DNA revealed only one band.
The DNA-binding domain of the htI protein has been
localized to a 118-amino-acid protein fragment that contains
four zinc fingers with the form Cys2-X12-His2. This con-
served motif, found in many DNA-binding proteins, was first
described for transcription factor TFIIIA (35). The consen-
sus sequence of the four fingers is Cys-X2-Cys-X3-Phe-X5-
Leu-X2-His-X3-His. Sequence analysis of the ht, protein
suggests that the negatively charged segment that can form
an a-helical structure may be involved in transcriptional
activation, as described for the yeast factors GCN4 and
GAL4 (24, 31, 38), AP-1 or Jun transcription factors (5, 46),
and the immunoglobulin heavy-chain enhancer-binding pro-
tein (4). The two basic segments may be involved in the
nuclear localization of ht,, as proposed by Dingwall and
Laskey (11).
The specific binding of the ht, protein to the human TCR
V,B8.1 promoter was shown by DNase I footprinting. Since
the portion of the htI protein that includes the zinc finger
region is able to bind DNA specifically, the zinc finger region
is most likely responsible for DNA binding. The binding site
contains approximately 16 nucleotides, GAAGTTGGG
GGTGGTG. In addition to binding to the human TCR V,B8.1
promoter, htf also binds to another T-cell regulatory se-
quence, mouse TCR a gene silencer I (Fig. 3). A comparison
of the binding sites in both the V,B8.1 promoter and a gene
silencer I revealed that the consensus sequence for htI
binding contains 9 nucleotides. This consensus sequence is
centered with a reversely oriented CACCC box that was first
(a)
ht[3
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characterized as an important promoter element for globin
gene expression (10). The CACCC/GGGTG sequence is
necessary for htI protein binding (Fig. 4). A gel shift assay
analysis of CACCC/GGGTG box mutants with the hti
protein may be necessary to determine the key nucleotides
essential for specific binding. A gel shift assay analysis with
the same CACCC/GGGTG-containing probe and nuclear
extracts from different cell lines revealed a number of bands.
Oligonucleotides representing the binding site of transcrip-
tion factor Spl can compete with htI for binding to the
CACCC box, although the competition is not as efficient as
that with CACCC box-containing oligonucleotides (data not
shown). This result suggests that the CACCC box-binding
proteins may interact with Spl-binding sites in gene regula-
tory sequences. No specific band is observed in nuclear
extracts from T cells. Interestingly, an extremely rapidly
moving band is detected in nuclear extracts from HeLa cells
but not from the three types of hematopoietic cells. Whether
this CACCC box-binding protein can regulate epithelial
cell-specific gene expression is not known. The question of
possible different forms of htI that can regulate gene expres-
sion is unanswered at this time. Also, a gel shift assay
analysis of the CACCC-containing probe with either in
vitro-translated protein from a full-length htp cDNA or cell
nuclear extracts may tell us which band in the gel shift assay
with nuclear extracts corresponds to the htI protein encoded
by the gene that we have cloned.
For determination of how many genes are possibly regu-
lated by the htI protein, different TCR genes were analyzed
for CACCC/GGGTG boxes. An examination of sequence
information from 14 mouse V,B and 5 human V,B gene
promoters (1, 45) revealed that most of the V38 family
members of both humans and mice contain the GGGTG box.
Only the mouse V538.1 gene and the human V38.4
pseudogene contain a modified GGGTG box. Among the
other VP members examined, only the mouse VP7 gene
contains a GGGTG box. It is clear that there must be other
transcription factors important for TCR expression, since
many V,B genes do not have CACCC/GGGTG box-binding
sites. In addition to VP genes, other TCR regulatory se-
quences also contain CACCC/GGGTG boxes, including
TCR a and 1 enhancers of both humans and mice (18, 22, 28,
52), and mouse TCR a gene silencers I and II (53). TCR
silencer I has four continuous repeats of the GGGTG box
and one CACCC box. A functional analysis is necessary to
determine whether these CACCC/GGGTG boxes bind to
transcription factors and activate gene expression. The
CACCC box is not found in the TCR y enhancer (25).
Although there is a CACCC box in the TCR 8 enhancer, a
DNase I footprinting assay revealed no binding activity at
that site (39). Sequences flanking the CACCC box may
provide specificity for htpi binding in T-cell nuclear extracts.
An approach to studying the specificity of htI binding to
TCR sequences would include examining the ability of the
hti-binding site in the V,B8.1 promoter to compete for the
binding site in the a gene silencer. We believe that the ht,B
protein may act as an activator for TCR gene expression by
binding to the CACCC/GGGTG boxes in the TCR a gene
silencer to reverse the silencing activity in a13 T cells. A
comparison of ht1 gene expression in a1 T cells versus -yb T
cells may provide important insight into the regulation of
TCR genes during ontogeny.
In addition to those in TCR genes, CACCC/GGGTG
boxes first were described in the globin gene promoter and
later were found in regulatory sequences of many genes.
Most of these CCCAC/GGGTG boxes are functional in the
transcriptional activation of these genes. The orientation of
the CACCC/GGGTG boxes may not have much influence on
transcription (44). Deletion of the ht,B-binding site, which has
a CACCC/GGGTG box in it, dramatically reduces transcrip-
tional activity, while the addition of five repeats of the
CACCC box to the deletion-containing V18.1 promoter
results in the restoration of transcriptional activity. The
results clearly show that the CACCC box is very important
for efficient transcription of the V18.1 promoter. Although
there is a CACCC box in the SV40 enhancer, it is not
important for transcription in this system. Plasmid
pAVP8.1CAT, which has a deletion of the CACCC box in
the V818.1 promoter but carries the CACCC box in the
SV40 enhancer, only expresses basal transcriptional activity
(Fig. 6). One study has shown that the upstream CACCC
box in the human 1-globin gene promoter is unable to bind
the CACCC factor, in contrast to the strong effect of the
proximal CACCC box on globin gene transcription. A
DNase I footprinting assay analysis (data not shown) indi-
cates that htp binds to the four continuous GGGTG boxes in
mouse a gene silencer I very well but that no significant
binding to the CACCC box located 101 nucleotides away is
observed. The sequences flanking the CACCC box may have
a significant effect on its ability to bind transcription factors.
Factors that bind to the flanking sequences may influence the
interaction between the CACCC box and its binding protein.
The importance of the CACCC box in gene transcription
was first shown in a study of the 1-globin promoter. The
C--T transition at the first position of the CACCC box in the
1-globin promoter strongly decreased transcription (10). A
CACCC box mutation in the slow/cardiac troponin C gene
enhancer also resulted in an approximately 90% reduction of
transcription relative to that observed with the wild-type
enhancer (36). Similar results were obtained for the mouse
porphobilinogen deaminase gene (37), the human 7S K RNA
gene (26), and GATA-1 gene promoters (49). The function of
the CACCC box in other TCR genes has yet to be deter-
mined. The cloning of the htp gene will allow further study of
the transcriptional regulation of other genes by a CACCC
box-binding protein. Another interesting aspect of the
CACCC box is that a mutation at this binding site can cause
disease. A mutation at position -87 (C- T or C-->G) in the
CACCC box of the globin promoter greatly decreases the
transcriptional activity of the ,B-globin gene, and a natural
mutation at that position has been shown to cause thalasse-
mia (15, 30). Our study also shows that the CACCC box is
important for TCR gene transcription. A mutation in the
CACCC box of the TCR promoter may cause the inefficient
expression of certain VP genes, therefore influencing the
immune response carried out by a population of T cells that
normally use that VP gene product together with a particular
Va gene product to recognize the major histocompatibility
complex molecule and foreign peptide.
The htp protein can reproducibly counteract the silencing
activity of mouse TCR a gene silencer I (Fig. 8). The
antagonizing activity of the htp protein for the TCR a gene
silencer may have interesting implications for TCR gene
expression in a13 and yB T cells. We speculate that perhaps
in yb T cells, either the htI protein is not expressed or the
htp protein is functionally different from that in ao3 T cells,
possibly because of (i) the posttranslational modification of
the htp protein, (ii) the accessibility of TCR a gene silencer
sequences to the htp protein, since a13 and yb T cells may
have different chromatin structures at the a/8 locus, (iii) the
concentration of the ht1 protein, or (iv) the combinatorial
interaction of the ht1 protein with different general transcrip-
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tion factors. The CACCC boxes in the TCR a gene silencer
may be inaccessible to the htI protein for any one of the
above-listed reasons, resulting in the silencing of the a locus
in -yb T cells. On the contrary, in a13 T cells, the actively
expressed ht3 protein may bind to the CACCC boxes in both
silencers I and II, resulting in the relief of silencing activity
and leading to the expression of the TCR a gene. The current
study, however, does not provide definite evidence that the
ht,B protein is the key player affecting ao3 versus -yS TCR
gene expression. The details of how the ht3 protein and
other transcription factors are involved in the TCR a gene
activity of af and -yb T cells may help to explain the process
of differentiation of these two populations of T cells. In
addition, how the interactions between the ht,B protein and
other transcription factors provide specificity in different
gene systems will be particularly interesting.
ACKNOWLEDGMENTS
We thank K. C. Cheng, Peter Mathisen, Sally Orr, Wenron Qiu,
David Wang, Kangsheng Wang, and Ebrahim Zandi for technical
advice during the course of this work. We also thank Jeffrey Leiden
for critical comments on this work. We are grateful to Peter
Mathisen and Erich Strauss for comments on the manuscript.
This work was supported in part by National Institutes of Health
grant HG00356. Y.W. also thanks the K. C. Wong Education
Foundation, Ltd., Hong Kong, for financial aid.
REFERENCES
1. Anderson, S. J., H. S. Chou, and D. Y. Loh. 1988. A conserved
sequence in the T-cell receptor 3-chain promoter region. Proc.
Natl. Acad. Sci. USA 85:3551-3554.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G.
Seidman, J. A. Smith, and K Struhl. 1987. Current protocols in
molecular biology. John Wiley & Sons, Inc., New York.
3. Aviv, H., and P. Leder. 1972. Purification of biologically active
globin messenger RNA by chromatography on oligothymidylic
acid-cellulose. Proc. Natl. Acad. Sci. USA 69:1408-1412.
4. Beckmann, H., L.-K. Su, and T. Kadesch. 1990. TFE3: a
helix-loop-helix protein that activates transcription through the
immunoglobulin enhancer ,E3 motif. Genes Dev. 4:167-179.
5. Bohmann, D., T. J. Bos, A. Admon, T. Nishmura, P. K. Vogt,
and R. Tjian. 1987. Human proto-oncogene C-Jun encodes a
DNA-binding protein with structural and functional properties
of transcription factor AP-1. Science 238:1386-1392.
6. Chien, Y. H., D. M. Becker, T. Lindsten, M. Okamura, D. I.
Cohen, and M. M. Davis. 1984. A third-type of murine T-cell
receptor gene. Nature (London) 312:31-35.
7. Chien, Y. H., M. Iwashima, K. B. Kaplan, J. F. Elliott, and
M. M. Davis. 1987. A new T-cell receptor gene located within
the alpha locus and expressed early in T-cell differentiation.
Nature (London) 327:677-682.
8. Chien, Y. H., M. Iwashima, D. A. Wettstien, K B. Kaplan, J. F.
Elliott, W. Born, and M. M. Davis. 1987. T-cell receptor delta
gene rearrangements in early thymocytes. Nature (London)
330:722-727.
9. Diamond, D. J., F. B. Nelson, and E. L. Reinherz. 1989.
Lineage-specific expression of a T cell receptor variable gene
promoter controlled by upstream sequences. J. Exp. Med.
169:1213-1231.
10. Dierks, P., A. van Ooyen, M. D. Cochran, C. Dobkin, J. Reiser,
and C. Weissman. 1983. Three regions upstream from the Cap
site are required for efficient and accurate transcription of the
rabbit 13-globin gene in mouse 3T6 cells. Cell 32:695-706.
11. Dingwall, C., and R A. Laskey. 1986. Protein import into the
cell nucleus. Annu. Rev. Cell Biol. 2:367-390.
12. Fan, C.-M., and T. Maniatis. 1990. A DNA-binding protein
containing two widely separated zinc finger motifs that recog-
nize the same DNA sequence. Genes Dev. 4:29-42.
13. Fujita, T., H. Shibuya, T. Ohashi, K. Yamanishi, and T.
Taniguchi. 1986. Regulation of the human interleukin-2 gene:
functional DNA sequence in the 5' flanking region for gene
expression in activated T lymphocytes. Cell 46:401-407.
14. Galas, D. J., and A. Schmitz. 1978. DNase footprinting: a simple
method for the detection of protein-DNA binding specificity.
Nucleic Acids Res. 5:3157-3171.
15. Giglioni, B., P. Comi, A. Ronchi, R. Mantovani, and S. Otto-
lenghi. 1989. The same nuclear proteins bind the proximal
CACCC box of the human I-globin promoter and a similar
sequence in the enhancer. Biochem. Biophys. Res. Commun.
164:149-155.
16. Giniger, E., S. M. Varnum, and M. Ptashne. 1985. Specific DNA
binding of GAL4, a positive regulatory protein of yeast. Cell
40:767-774.
17. Gorman, C., L. Moffat, and B. Howard. 1982. Recombinant
genomes which express chloramphenicol acetyltransferase in
mammalian cells. Mol. Cell. Biol. 2:1044 1051.
18. Gottschalk, L. R., and J. M. Leiden. 1990. Identification and
functional characterization of the human T-cell receptor ,B gene
transcriptional enhancer: common nuclear proteins interact
with the transcriptional regulatory elements of the T-cell recep-
tor a and ,B genes. Mol. Cell. Biol. 10:5486-5495.
19. Govindan, M. V., F. Pothier, S. Leclerc, R. Palaniswami, and M.
Xie. 1991. Human glucocorticoid receptor gene promoter-
homologous down regulation. J. Steroid Biochem. Mol. Biol.
40:317-323.
20. Hedrick, S. M., E. A. Nielsen, J. Kavaler, D. I. Cohen, and
M. M. Davis. 1984. Sequence relationships between putative
T-cell receptor polypeptides and immunoglobulins. Nature
(London) 308:149-153.
21. Ho, I.-C., N. K. Bhat, L. R. Gottschalk, T. Lindsten, C. B.
Thompson, T. K. Papas, and J. M. Leiden. 1990. Sequence-
specific binding of human Ets-1 to the T cell receptor gene
enhancer. Science 250:814-818.
22. Ho, I.-C., L.-H. Yang, G. Morle, and J. M. Leiden. 1989. A
T-cell specific transcriptional enhancer element 3' of Ca in the
human T-cell receptor locus. Proc. Natl. Acad. Sci. USA
86:6714-6718.
23. Hoey, T., and M. Levine. 1988. Divergent homeobox proteins
recognize similar DNA sequences in Drosophila. Nature (Lon-
don) 332:858-861.
24. Hope, I. A., and K. Struhl. 1985. GCN4 protein, synthesized in
vitro, binds HIS3 regulatory sequences: implication for general
control of amino acid biosynthetic genes in yeast. Cell 43:177-
188.
25. Kappes, D. J., C. P. Browne, and S. Tonegawa. 1991. Identifi-
cation of a T-cell-specific enhancer at the locus encoding T-cell
antigen receptor -y chain. Proc. Natl. Acad. Sci. USA 88:2204-
2208.
26. Kleinert, H., R. Assert, and B.-J. Benecke. 1991. A single base
pair deletion from the inactive octamer-like motif of the 7S K
RNA distal sequence element brings full functionality in vivo. J.
Biol. Chem. 266:23872-23877.
27. Kranz, D. M., H. Saito, M. Heller, Y. Takagaki, W. Haas, H. N.
Eisen, and S. Tonegawa. 1985. Limited diversity of the rear-
ranged T-cell gene. Nature (London) 313:752-755.
28. Krimpenfort, P., R. de Jong, Y. Uematsu, Z. Dembic, S. Ryer,
H. von Boehmer, M. Steinmetz, and B. Berns. 1988. Transcrip-
tion of T cell receptor 13-chain gene is controlled by a down-
stream regulatory element. EMBO J. 7:745-750.
29. Kronenberg, M., G. Siu, L. Hood, and N. Shastri. 1986. The
molecular genetics of the T-cell antigen receptor and T-cell
antigen recognition. Annu. Rev. Immunol. 4:529-591.
30. Kulozik, A. E., A. Bellan-Koch, S. Bail, E. Kohne, and E.
Kienhauer. 1991. Thalassemia intermedia: moderate reduction
of 3-globin gene transcription activity by a novel mutation of the
proximal CACCC promoter element. Blood 77:2054-2058.
31. Ma, J., and M. Ptashne. 1987. A new class of yeast transcrip-
tional activators. Cell 51:113-119.
32. Maeda, M., K.-I. Oshuma, S. Tamura, S. Kaya, S. Mahood,
M. A. Reuben, L. S. Lasater, G. Sachs, and M. Futai. 1991. The
rat H+/K+-ATPase e subunit gene and recognition of its control
region by gastric DNA binding protein. J. Biol. Chem. 266:
21584-21588.
MOL. CELL. BIOL.
REGULATION OF TCR GENE EXPRESSION BY htI 5701
33. Maniatis, T., E. F. Fritsch, and J. Sambrook 1989. Molecular
cloning: a laboratory manual. Cold Spring Harbor Laboratory,
Cold Spring Harbor, N.Y.
34. McDougall, S., C. L. Peterson, and K. Calame. 1988. A tran-
scriptional enhancer 3' of C132 in the T cell receptor ,B locus.
Science 241:205-208.
35. Miller, J., A. D. McLachlan, and A. Klug. 1985. Repetitive
zinc-binding domains in the protein transcription factor IIIA
from Xenopus oocytes. EMBO J. 4:1609-1614.
36. Parmacek, M. S., A. J. Vora, T. Shen, E. Barr, F. Jung, and
J. M. Leiden. 1992. Identification and characterization of a
cardiac-specific transcriptional regulatory element in the slow/
cardiac troponin C gene. Mol. Cell. Biol. 12:1967-1976.
37. Porcher, C., G. Pitiot, M. Plumb, S. Lowe, H. de Verneuil, and
B. Grandchamp. 1991. Characterization of hypersensitive sites,
protein binding motifs, and regulatory elements in both promot-
ers of the mouse porphobilinogen deaminase gene. J. Biol.
Chem. 266:10562-10569.
38. Ptashne, M. 1988. How eukaryotic transcriptional activation
works. Nature (London) 335:683-689.
39. Redondo, J. M., S. Hata, C. Brocklehurst, and M. S. Krangel.
1990. A T cell-specific transcriptional enhancer within the
human T cell receptor 8 locus. Science 247:1225-1229.
40. Royer, H. D., and E. L. Reinherz. 1987. Multiple nuclear
proteins bind upstream sequences in the promoter region of a
T-cell receptor beta-chain variable region gene: evidence for
tissue specificity. Proc. Natl. Acad. Sci. USA 84:232-236.
41. Saito, H. D., M. Kranz, Y. Takagaki, A. C. Hayday, H. N. Eisen,
and S. Tonegawa. 1984. Complete primary structure of a het-
erodimeric T-cell receptor deduced from cDNA sequence. Na-
ture (London) 309:757-762.
42. Saito, H. D., M. Kranz, Y. Takagaki, A. C. Hayday, H. N. Eisen,
and S. Tonegawa. 1984. A third rearranged and expressed gene
in a clone of cytotoxic T lymphocytes. Nature (London) 312:
36-40.
43. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner.
1988. Identification of a novel lymphoid specific binding protein
(OTF-2B) by proteolytic clipping bandshift assay (PCBA).
EMBO J. 7:4221-4229.
44. Schule, R., M. Muller, H. Otsuka-Murakami, and R. Renkawith.
1988. Cooperativity of the glucocorticoid receptor and the
CACCC-box binding factor. Nature (London) 332:87-90.
45. Siu, G., E. C. Strauss, L. Lai, and L. Hood. 1986. Analysis of a
human VP gene subfamily. J. Exp. Med. 164:1600-1614.
46. Struhl, K. 1988. The Jun oncoprotein, a vertebrate transcription
factor, activates transcription in yeast. Nature (London) 332:
649-650.
47. Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W.
Dubendorff. 1990. Use of T7 RNA polymerase to direct the
expression of cloned genes. Methods Enzymol. 185:60-89.
48. Treisman, J., and C. Desplan. 1989. The products of the
Drosophila GAP genes hunchback and kruppel bind to the
hunchback promoters. Nature (London) 341:335-337.
49. Tsai, S.-F., E. Strauss, and S. H. Orkin. 1991. Functional
analysis and in vivo footprinting implicate the erythroid tran-
scription factor GATA-1 as a positive regulator of its own
promoter. Genes Dev. 5:919-931.
50. Vinson, C. R., K. L. Lamarco, P. E. Johnson, W. H. Landschulz,
and S. L. McKnight. 1988. In situ detection of sequence-specific
DNA binding activity specified by a recombinant bacteriophage.
Genes Dev. 2:801-806.
51. Waterman, M. L., and K. A. Jones. 1990. Purification of
TCF-la, a T-cell-specific transcription factor that activates the
T-cell receptor Ca gene enhancer in a context-dependent man-
ner. New Biol. 2:621-636.
52. Winoto, A., and D. Baltimore. 1989. A novel, inducible and
T-cell specific enhancer located at the 3' end of the T cell
receptor a locus. EMBO J. 8:729-733.
53. Winoto, A., and D. Baltimore. 1989. ao3 lineage-specific expres-
sion of the a T cell receptor gene by nearby silencers. Cell
59:649-655.
54. Winoto, A., S. Mjolsness, and L. Hood. 1985. Genomic organi-
zation of the gene encoding the mouse T-cell receptor a chain.
Nature (London) 316:832-836.
55. Xu, M., and J. Stavnezer. 1992. Regulation of transcription of
immunoglobulin germ-line -yl RNA, analysis of the promoter/
enhancer. EMBO J. 11:145-155.
56. Yanagi, Y., Y. Yoshikai, K. Leggette, S. Clark, I. Aieksander,
and T. W. Mak. 1984. A human T cell-specific cDNA clone
encodes a protein having extensive homology to immunoglobu-
lin chains. Nature (London) 308:145-149.
VOL. 13, 1993
